Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that it will host a conference call and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback